Cite

HARVARD Citation

    Temizoz, B. et al. (n.d.). TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN. European journal of immunology. 45 (4), pp. 1159-1169. [Online]. 
  
Back to record